Your browser doesn't support javascript.
loading
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study.
Janczewska, Ewa; Zarebska-Michaluk, Dorota; Berak, Hanna; Piekarska, Anna; Gietka, Andrzej; Dybowska, Dorota; Mazur, Wlodzimierz; Belica-Wdowik, Teresa; Dobracki, Witold; Tudrujek-Zdunek, Magdalena; Deron, Zbigniew; Buczynska, Iwona; Sitko, Marek; Czauz-Andrzejuk, Agnieszka; Lorenc, Beata; Bialkowska-Warzecha, Jolanta; Citko, Jolanta; Laurans, Lukasz; Jaroszewicz, Jerzy; Socha, Lukasz; Tronina, Olga; Adamek, Brygida; Horban, Andrzej; Halota, Waldemar; Baka-Cwierz, Barbara; Tomasiewicz, Krzysztof; Simon, Krzysztof; Garlicki, Aleksander; Wawrzynowicz-Syczewska, Marta; Flisiak, Robert.
Afiliación
  • Janczewska E; Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia, ID Clinic, Janowska 19, 41-400 Myslowice, Bytom, Poland. e.janczewska@poczta.fm.
  • Zarebska-Michaluk D; Department of Infectious Diseases, Wojewódzki Szpital Zespolony, UJK Kielce, Poland.
  • Berak H; Hospital of Infectious Diseases, Warszawa, Poland.
  • Piekarska A; Department of Infectious Diseases and Hepatology, Medical University of Lódz, Lódz, Poland.
  • Gietka A; Department of Internal Medicine and Hepatology, Central Clinical Hospital of the MSWiA, Warszawa, Poland.
  • Dybowska D; Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University Torun, Bydgoszcz, Poland.
  • Mazur W; Department of Infectious Diseases, Infectious Hepatology and Acquired Immunodeficiency, Medical University of Silesia in Katowice, Chorzów, Poland.
  • Belica-Wdowik T; Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, John Paul II Hospital, Kraków, Poland.
  • Dobracki W; MED-FIX Medical Center, Wroclaw, Poland.
  • Tudrujek-Zdunek M; Department of Infectious Diseases, Medical University of Lublin, Lublin, Poland.
  • Deron Z; Ward of Infectious Diseases and Hepatology, Bieganski Regional Specialist Hospital, Lódz, Poland.
  • Buczynska I; Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Wroclaw, Poland.
  • Sitko M; Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University, Kraków, Poland.
  • Czauz-Andrzejuk A; Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
  • Lorenc B; Pomeranian Center of Infectious Diseases, Department of Infectious Diseases, Medical University of Gdansk, Gdansk, Poland.
  • Bialkowska-Warzecha J; Department of Infectious and Liver Diseases, Medical University of Lódz, Lódz, Poland.
  • Citko J; Medical Practice of Infections, Regional Hospital, Olsztyn, Poland.
  • Laurans L; Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, Szczecin, Poland.
  • Jaroszewicz J; Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Bytom, Poland.
  • Socha L; Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, Szczecin, Poland.
  • Tronina O; Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Warszawa, Poland.
  • Adamek B; Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia, ID Clinic, Janowska 19, 41-400 Myslowice, Bytom, Poland.
  • Horban A; Warsaw Medical University & Hospital of Infectious Diseases Warszawa, Warszawa, Poland.
  • Halota W; Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University Torun, Bydgoszcz, Poland.
  • Baka-Cwierz B; Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, John Paul II Hospital, Kraków, Poland.
  • Tomasiewicz K; Department of Infectious Diseases, Medical University of Lublin, Lublin, Poland.
  • Simon K; Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Wroclaw, Poland.
  • Garlicki A; Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University, Kraków, Poland.
  • Wawrzynowicz-Syczewska M; Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, Szczecin, Poland.
  • Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
BMC Infect Dis ; 18(1): 580, 2018 Nov 16.
Article en En | MEDLINE | ID: mdl-30445916
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Uracilo / Uridina Monofosfato / Bencimidazoles / Carbamatos / Ritonavir / Hepatitis C Crónica / Farmacorresistencia Viral Múltiple / Compuestos Macrocíclicos / Fluorenos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Uracilo / Uridina Monofosfato / Bencimidazoles / Carbamatos / Ritonavir / Hepatitis C Crónica / Farmacorresistencia Viral Múltiple / Compuestos Macrocíclicos / Fluorenos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Reino Unido